Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia
Sign Up to like & getrecommendations! Published in 2020 at "Blood Purification"
DOI: 10.1159/000511725
Abstract: We report a preliminary experience of adjuvant therapy with Hemoperfusion (HP) in patients with Severe Acute Respiratory Syndrome-CoronaVirus 2 (SARS-CoV2) pneumonia. Currently, there are no approved treatments for CoronaVirus Disease 19 (COVID-19); however, therapeutic strategies… read more here.
Keywords: hemoperfusion; cov2 pneumonia; sars cov2; respiratory ... See more keywords